Claudia A Jette
Overview
Explore the profile of Claudia A Jette including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
1376
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barnes C, Jette C, Abernathy M, Dam K, Esswein S, Gristick H, et al.
Nature
. 2024 Apr;
628(8008):E2.
PMID: 38565636
No abstract available.
2.
Partin A, Bruno R, Shafaattalab S, Mause E, Winters A, Daris M, et al.
Front Immunol
. 2024 Feb;
15:1304765.
PMID: 38343543
Clinical applications of CAR-T cells are limited by the scarcity of tumor-specific targets and are often afflicted with the same on-target/off-tumor toxicities that plague other cancer treatments. A new promising...
3.
Mock J, Winters A, Riley T, Bruno R, Naradikian M, Sharma S, et al.
Mol Ther Oncolytics
. 2022 Nov;
27:157-166.
PMID: 36381658
Innovative cell-based therapies are important new weapons in the fight against difficult-to-treat cancers. One promising strategy involves cell therapies equipped with multiple receptors to integrate signals from more than one...
4.
Cohen A, van Doremalen N, Greaney A, Andersen H, Sharma A, Starr T, et al.
Science
. 2022 Jul;
377(6606):eabq0839.
PMID: 35857620
To combat future severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants and spillovers of SARS-like betacoronaviruses (sarbecoviruses) threatening global health, we designed mosaic nanoparticles that present randomly arranged sarbecovirus spike...
5.
Bley C, Nie S, Mobbs G, Petrovic S, Gres A, Liu X, et al.
Science
. 2022 Jun;
376(6598):eabm9129.
PMID: 35679405
INTRODUCTION The subcellular compartmentalization of eukaryotic cells requires selective transport of folded proteins and protein-nucleic acid complexes. Embedded in nuclear envelope pores, which are generated by the circumscribed fusion of...
6.
Cohen A, van Doremalen N, Greaney A, Andersen H, Sharma A, Starr T, et al.
bioRxiv
. 2022 Apr;
PMID: 35378752
To combat future SARS-CoV-2 variants and spillovers of SARS-like betacoronaviruses (sarbecoviruses) threatening global health, we designed mosaic nanoparticles presenting randomly-arranged sarbecovirus spike receptor-binding domains (RBDs) to elicit antibodies against conserved/relatively-occluded,...
7.
Jette C, Cohen A, Gnanapragasam P, Muecksch F, Lee Y, Huey-Tubman K, et al.
Cell Rep
. 2021 Dec;
37(12):110188.
PMID: 34936878
No abstract available.
8.
Abernathy M, Dam K, Esswein S, Jette C, Bjorkman P
Viruses
. 2021 Oct;
13(10).
PMID: 34696536
The H1N1 pandemic of 2009-2010, MERS epidemic of 2012, Ebola epidemics of 2013-2016 and 2018-2020, Zika epidemic of 2015-2016, and COVID-19 pandemic of 2019-2021, are recent examples in the long...
9.
Jette C, Cohen A, Gnanapragasam P, Muecksch F, Lee Y, Huey-Tubman K, et al.
Cell Rep
. 2021 Sep;
36(13):109760.
PMID: 34534459
Many anti-severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2) neutralizing antibodies target the angiotensin-converting enzyme 2 (ACE2) binding site on viral spike receptor-binding domains (RBDs). Potent antibodies recognize exposed variable epitopes,...
10.
Jette C, Cohen A, Gnanapragasam P, Muecksch F, Lee Y, Huey-Tubman K, et al.
bioRxiv
. 2021 May;
PMID: 33948592
Many anti-SARS-CoV-2 neutralizing antibodies target the ACE2-binding site on viral spike receptor-binding domains (RBDs). The most potent antibodies recognize exposed variable epitopes, often rendering them ineffective against other sarbecoviruses and...